Literature DB >> 17114370

Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story.

D M Mannino.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17114370      PMCID： PMC2117065          DOI： 10.1136/thx.2006.067785

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  19 in total

1.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994.

Authors:  D M Mannino; R C Gagnon; T L Petty; E Lydick
Journal:  Arch Intern Med       Date:  2000-06-12

2.  Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey.

Authors:  Eva Hnizdo; Patricia A Sullivan; Ki Moon Bang; Gregory Wagner
Journal:  Am J Epidemiol       Date:  2002-10-15       Impact factor: 4.897

3.  The occupational burden of chronic obstructive pulmonary disease.

Authors:  L Trupin; G Earnest; M San Pedro; J R Balmes; M D Eisner; E Yelin; P P Katz; P D Blanc
Journal:  Eur Respir J       Date:  2003-09       Impact factor: 16.671

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

5.  Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.

Authors:  B Lundbäck; A Lindberg; M Lindström; E Rönmark; A C Jonsson; E Jönsson; L G Larsson; S Andersson; T Sandström; K Larsson
Journal:  Respir Med       Date:  2003-02       Impact factor: 3.415

6.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

7.  The TORCH (towards a revolution in COPD health) survival study protocol.

Authors:  J Vestbo
Journal:  Eur Respir J       Date:  2004-08       Impact factor: 16.671

Review 8.  Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes.

Authors:  A S Buist
Journal:  Eur Respir J Suppl       Date:  2003-01

9.  Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study.

Authors:  D M Mannino; A S Buist; T L Petty; P L Enright; S C Redd
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 10.  The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation.

Authors:  B W M Willemse; D S Postma; W Timens; N H T ten Hacken
Journal:  Eur Respir J       Date:  2004-03       Impact factor: 16.671
View more
  4 in total

1.  Spirometric testing on World COPD Day.

Authors:  Tanja Grzetic-Romcevic; Boris Devcic; Silvana Sonc
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-02-10

2.  COPD and asthma in patients with opioid dependency: a cross-sectional study in primary care.

Authors:  S Mehta; N Parmar; M Kelleher; C J Jolley; P White; S Durbaba; M Ashworth
Journal:  NPJ Prim Care Respir Med       Date:  2020-01-14       Impact factor: 2.871

3.  Determining the influence of the primary and specialist network of care on patient and system outcomes among patients with a new diagnosis of chronic obstructive pulmonary disease (COPD).

Authors:  J Tranmer; T Rotter; D O'Donnell; D Marciniuk; M Green; L Kinsman; W Li
Journal:  BMC Health Serv Res       Date:  2022-09-29       Impact factor: 2.908

4.  Prevalence of chronic obstructive pulmonary disease among patients with systemic arterial hypertension without respiratory symptoms.

Authors:  Marcelo Fouad Rabahi; Sheila Alves Pereira; José Laerte Rodrigues Silva Júnior; Aline Pacheco de Rezende; Adeliane Castro da Costa; Krislainy de Sousa Corrêa; Marcus Barreto Conde
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.